Related Experiment Videos

[Infectious complications after liver transplantation]

C Moncorge1, M Matmar

  • 1Département d'Anesthésie-Réanimation, Groupe Hospitalier Cochin, Paris.

Annales De Radiologie
|January 1, 1994
PubMed

Insights

Liver transplant recipients frequently experience infections, a leading cause of death. Prophylactic antibiotics, antifungals, and immunoglobulins can reduce infection rates, while antiviral treatments remain effective.

Area of Science:

  • Infectious Diseases
  • Transplantation Medicine
  • Immunology

Context:

  • Infections are a major complication following liver transplantation, contributing significantly to patient mortality.
  • Risk factors for bacterial and fungal infections include preoperative status, surgical factors, and immunosuppression levels.
  • Viral infections, particularly cytomegalovirus (CMV), pose a significant threat to transplant recipients.

Purpose:

  • To review the incidence and management of infections after liver transplantation.
  • To highlight the role of prophylactic measures in reducing infection rates.
  • To discuss the effectiveness of antiviral treatments for established viral infections.

Summary:

  • Bacterial and fungal infections are common post-liver transplant and are influenced by patient condition, surgical details, and immunosuppression.
  • Prophylactic perioperative antibiotics and antifungal agents can decrease infection incidence.
  • Cytomegalovirus (CMV) is a primary viral concern, with immunoglobulin prophylaxis recommended for high-risk patients and effective antiviral therapy available.

Impact:

  • Understanding infection risks and implementing appropriate prophylaxis is crucial for improving outcomes in liver transplant patients.
  • Effective management strategies can mitigate the leading cause of mortality in this vulnerable population.
  • This review provides insights into optimizing infection control protocols in liver transplantation.

Related Concept Videos